Method for manufacturing transdermally delivered hyaluronic acid-protein conjugate and transdermally delivered hyaluronic acid-protein conjugate manufactured using same
US10092658B2 · kind B2 · utility
0Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 2013 |
| Grant date | Oct 9, 2018 |
| Priority date | — |
| Expiry date | Feb 7, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/91
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A transdermal delivery system of drug and a method of preparing the same are provided. More specifically, the invention can be a transdermal delivery system applied for various protein drugs such as vaccines and chemical drugs, because the drug delivery system has a biocompatibility, biodegradation property, transdermal delivery property, the safety of human body, maximum activity of protein drugs, good bio-conjugation efficiency and a long-term efficacy, a method of preparing the same and its use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.